Literature DB >> 27784781

Autotaxin Expression Is Regulated at the Post-transcriptional Level by the RNA-binding Proteins HuR and AUF1.

Shuhong Sun1, Xiaotian Zhang2, Lin Lyu1, Xixi Li3, Siliang Yao1, Junjie Zhang4.   

Abstract

Autotaxin (ATX) is a key enzyme that converts lysophosphatidylcholine (LPC) into lysophosphatidic acid (LPA), a lysophospholipid mediator that regulates cellular activities through its specific G protein-coupled receptors. The ATX-LPA axis plays an important role in various physiological and pathological processes, especially in inflammation and cancer development. Although the transcriptional regulation of ATX has been widely studied, the post-transcriptional regulation of ATX is largely unknown. In this study, we identified conserved adenylate-uridylate (AU)-rich elements in the ATX mRNA 3'-untranslated region (3'UTR). The RNA-binding proteins HuR and AUF1 directly bound to the ATX mRNA 3'UTR and had antagonistic functions in ATX expression. HuR enhanced ATX expression by increasing ATX mRNA stability, whereas AUF1 suppressed ATX expression by promoting ATX mRNA decay. HuR and AUF1 were involved in ATX regulation in Colo320 human colon cancer cells and the LPS-stimulated human monocytic THP-1 cells. HuR knockdown suppressed ATX expression in B16 mouse melanoma cells, leading to inhibition of cell migration. This effect was reversed by AUF1 knockdown to recover ATX expression or by the addition of LPA. These results suggest that the post-transcriptional regulation of ATX expression by HuR and AUF1 modulates cancer cell migration. In summary, we identified HuR and AUF1 as novel post-transcriptional regulators of ATX expression, thereby elucidating a novel mechanism regulating the ATX-LPA axis.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  AU-rich element RNA-binding protein 1 (AUF1); ELAV-like protein 1 (HuR (human antigen R)); RNA-binding protein; lysophospholipid; post-transcriptional regulation

Mesh:

Substances:

Year:  2016        PMID: 27784781      PMCID: PMC5207058          DOI: 10.1074/jbc.M116.756908

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Identification of genes associated with metastasis of mammary carcinoma in metastatic versus non-metastatic cell lines.

Authors:  Nicole Euer; Marina Schwirzke; Vesna Evtimova; Helmut Burtscher; Michael Jarsch; David Tarin; Ulrich H Weidle
Journal:  Anticancer Res       Date:  2002 Mar-Apr       Impact factor: 2.480

2.  Identification of a target RNA motif for RNA-binding protein HuR.

Authors:  Isabel López de Silanes; Ming Zhan; Ashish Lal; Xiaoling Yang; Myriam Gorospe
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-23       Impact factor: 11.205

Review 3.  The role of AUF1 in regulated mRNA decay.

Authors:  Frances M Gratacós; Gary Brewer
Journal:  Wiley Interdiscip Rev RNA       Date:  2010 Nov-Dec       Impact factor: 9.957

4.  HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer.

Authors:  Xiaofang Yi; Yi Zhou; Wenxin Zheng; Setsuko K Chambers
Journal:  Aust N Z J Obstet Gynaecol       Date:  2009-02       Impact factor: 2.100

5.  The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis.

Authors:  Lisa E Young; Sandhya Sanduja; Kristi Bemis-Standoli; Edsel A Pena; Robert L Price; Dan A Dixon
Journal:  Gastroenterology       Date:  2009-01-15       Impact factor: 22.682

6.  Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.

Authors:  Shuying Liu; Makiko Umezu-Goto; Mandi Murph; Yiling Lu; Wenbin Liu; Fan Zhang; Shuangxing Yu; L Clifton Stephens; Xiaojiang Cui; George Murrow; Kevin Coombes; William Muller; Mien-Chie Hung; Charles M Perou; Adrian V Lee; Xianjun Fang; Gordon B Mills
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

7.  Expression, regulation and function of autotaxin in thyroid carcinomas.

Authors:  Astrid Kehlen; Nadine Englert; Anja Seifert; Thomas Klonisch; Henning Dralle; Jürgen Langner; Cuong Hoang-Vu
Journal:  Int J Cancer       Date:  2004-05-10       Impact factor: 7.396

8.  Lipopolysaccharide induces autotaxin expression in human monocytic THP-1 cells.

Authors:  Song Li; Junjie Zhang
Journal:  Biochem Biophys Res Commun       Date:  2008-11-21       Impact factor: 3.575

Review 9.  Modulation of neoplastic gene regulatory pathways by the RNA-binding factor AUF1.

Authors:  Beth E Zucconi; Gerald M Wilson
Journal:  Front Biosci (Landmark Ed)       Date:  2011-06-01

10.  AREsite: a database for the comprehensive investigation of AU-rich elements.

Authors:  Andreas R Gruber; Jörg Fallmann; Franz Kratochvill; Pavel Kovarik; Ivo L Hofacker
Journal:  Nucleic Acids Res       Date:  2010-11-11       Impact factor: 16.971

View more
  14 in total

Review 1.  The Interplay between the RNA Decay and Translation Machinery in Eukaryotes.

Authors:  Adam M Heck; Jeffrey Wilusz
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

2.  TERC suppresses PD-L1 expression by downregulating RNA binding protein HuR.

Authors:  Heping Jin; Yanlian Chen; Jian Ren; Junjiu Huang; Yong Zhao; Haiying Liu
Journal:  Sci China Life Sci       Date:  2022-06-01       Impact factor: 6.038

3.  Versatile activity and morphological effects of zinc oxide submicron particles as anticancer agents.

Authors:  Junnan Geng; Gregory Jensen; Kyle Jackson; Jefferson Pontsler; Venkatakrishnan Rengarajan; Yan Sun; David Britt; Yu Huang
Journal:  Nanomedicine (Lond)       Date:  2022-03-30       Impact factor: 6.096

Review 4.  RNA-binding proteins and their role in kidney disease.

Authors:  Michael Ignarski; Roman-Ulrich Müller; Lisa Seufert; Thomas Benzing
Journal:  Nat Rev Nephrol       Date:  2021-11-03       Impact factor: 42.439

5.  Autotaxin loss accelerates intestinal inflammation by suppressing TLR4-mediated immune responses.

Authors:  Su Jin Kim; Cody Howe; Jonathon Mitchell; Jieun Choo; Alexandra Powers; Angelos Oikonomopoulos; Charalabos Pothoulakis; Daniel W Hommes; Eunok Im; Sang Hoon Rhee
Journal:  EMBO Rep       Date:  2020-09-01       Impact factor: 8.807

Review 6.  Understanding and targeting the disease-related RNA binding protein human antigen R (HuR).

Authors:  Christopher W Schultz; Ranjan Preet; Teena Dhir; Dan A Dixon; Jonathan R Brody
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-01-23       Impact factor: 9.957

Review 7.  Autotaxin in Pathophysiology and Pulmonary Fibrosis.

Authors:  Ioanna Ninou; Christiana Magkrioti; Vassilis Aidinis
Journal:  Front Med (Lausanne)       Date:  2018-06-13

8.  Autotaxin is a novel target of microRNA-101-3p.

Authors:  Yuqin Wang; Lin Lyu; Xiaotian Zhang; Junjie Zhang
Journal:  FEBS Open Bio       Date:  2019-03-01       Impact factor: 2.693

9.  Characterization of novel LncRNA P14AS as a protector of ANRIL through AUF1 binding in human cells.

Authors:  Wanru Ma; Juanli Qiao; Jing Zhou; Liankun Gu; Dajun Deng
Journal:  Mol Cancer       Date:  2020-02-27       Impact factor: 27.401

Review 10.  Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.

Authors:  Matthew G K Benesch; Iain T K MacIntyre; Todd P W McMullen; David N Brindley
Journal:  Cancers (Basel)       Date:  2018-03-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.